Patients with significant dyslipidaemia require appropriate lipid-lowering therapy according to NICE guideline NG238
To help with that, MeAgain's GLP-1 app lets you track doses and lab results, flags likely effects on tests, and stores notes you can share with your clinician
Preserving metabolically active tissues supports physical function, sustains resting energy expenditure, and reduces the risk of rapid weight regain, thereby enhancing the long-term success and cost-effectiveness of obesity treatments [8, 22,23,24,25]
The product is easy to use and a good price
Strength training and enough protein protect lean muscle mass, according to the American Diabetes Association, and losing that muscle (sometimes called sarcopenia) is a real risk with GLP-1 medications